Evidence map›Paper›PMID 35803914›Full record

ArticleNature communications2022

Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells.

Philip S Robinson, Laura E Thomas, Federico Abascal, Hyunchul Jung, Luke M R Harvey, Hannah D West, Sigurgeir Olafsson, Bernard C H Lee, Tim H H Coorens, Henry Lee-Six and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 59 citations in OpenAlex.

  1. Dynamics of mutators of arbitrary dominance in humans.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. A sibling study of variation in parental mutation rates.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 4 countries.

Philip S RobinsonCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.ORCID 0000-0002-6237-7159
Laura E ThomasInstitute of Life Science, Swansea University, Swansea, SA28PP, UK.ORCID 0000-0002-8621-5285
Federico AbascalCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.ORCID 0000-0002-6201-1587
Hyunchul JungCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Luke M R HarveyCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Hannah D WestInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Sigurgeir OlafssonCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Bernard C H LeeCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Tim H H CoorensCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.ORCID 0000-0002-5826-3554
Henry Lee-SixCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.ORCID 0000-0003-4831-8088
Laura ButlinInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.ORCID 0000-0003-2753-1883
Nicola LanderInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Rebekah TruscottInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Mathijs A SandersCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Stefanie V LensingCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Simon J A BuczackiNuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Rogier Ten HoopenDepartment of Oncology, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0655-9182
Nicholas ColemanDepartment of Pathology, University of Cambridge, Cambridge, UK.
Roxanne Brunton-SimNorfolk and Norwich University Hospital, Norwich, UK.
Simon RushbrookNorfolk and Norwich University Hospital, Norwich, UK.
Kourosh Saeb-ParsyDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0633-3696
Fiona LallooManchester Centre for Genomic Medicine, Saint Mary's Hospital, Oxford Road, Manchester, UK.
Peter J CampbellCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Iñigo MartincorenaCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.ORCID 0000-0003-1122-4416
Julian R SampsonInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Michael R StrattonCancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, CB10 1SA, UK. mrs@sanger.ac.uk.ORCID 0000-0001-6035-153X
Wellcome Sanger Institute · GBCardiff University · GBUniversity of Cambridge · GBNorfolk and Norwich University Hospital · GBNuffield Orthopaedic Centre · GBQueen Mary Hospital · CNSt Mary's Hospital · GBSwansea University · GBUniversity of East Anglia · GB

Funding

Cancer Research UK 21777Wellcome Trust 206194
6 · The paper itself

Abstract

Cellular DNA damage caused by reactive oxygen species is repaired by the base excision repair (BER) pathway which includes the DNA glycosylase MUTYH. Inherited biallelic MUTYH mutations cause predisposition to colorectal adenomas and carcinoma. However, the mechanistic progression from germline MUTYH mutations to MUTYH-Associated Polyposis (MAP) is incompletely understood. Here, we sequence normal tissue DNAs from 10 individuals with MAP. Somatic base substitution mutation rates in intestinal epithelial cells were elevated 2 to 4-fold in all individuals, except for one showing a 31-fold increase, and were also increased in other tissues. The increased mutation burdens were of multiple mutational signatures characterised by C > A changes. Different mutation rates and signatures between individuals are likely due to different MUTYH mutations or additional inherited mutations in other BER pathway genes. The elevated base substitution rate in normal cells likely accounts for the predisposition to neoplasia in MAP. Despite ubiquitously elevated mutation rates, individuals with MAP do not display overt evidence of premature ageing. Thus, accumulation of somatic mutations may not be sufficient to cause the global organismal functional decline of ageing.

Indexed as

Adenomatous Polyposis ColiColorectal NeoplasmsDNA GlycosylasesGenetic Predisposition to DiseaseGerm-Line MutationHumansMutationMutation RateDNA GlycosylasesmutY adenine glycosylase

Identifiers

PMID35803914
PMCPMC9270427
OpenAlexW4284895155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.